The IGHG2 expression was previously detected enhanced in cancer tissues of CRC patients but not in plasma.54 Further analysis in larger cohorts will validate our findings to determine the suitability of these potential biomarkers to predict the cancer stage and the association with inflammation. The gene discussed is IGHG2; the disease is colorectal carcinoma.